Despite advances in medical therapy for patients with stage C heart failure (HF), survival for
patients with advanced HF is< 20% at 5 years. Durable left ventricular assist device (dLVAD) …

Life expectancy of patients with a durable, continuous-flow left ventricular assist device (CF-
LVAD) continues to increase. Despite significant improvements in the delivery of care for …

We describe waiting times for pediatric heart transplant (HT) candidates after the 2016
revision to the US allocation policy. The OPTN database was queried for pediatric HT …

Background Learning health networks (LHN) are consortia of institutions that collaborate
and embrace the elements of the learning health system (LHS), including quality …

Background Research evaluating hemostatic agents for the treatment of clinically significant
bleeding has been hampered by inconsistency and lack of standardized primary clinical trial …

Objectives Activated partial thromboplastin time (aPTT) is the primary test used to monitor
intravenous (IV) direct thrombin inhibitors (DTIs) but has many limitations. The plasma …

The field of pediatric ventricular assist device (VAD) support has expanded significantly over
the past 20 years, with one third of pediatric heart transplant recipients currently being …

Background Learning networks have emerged in medicine as a novel organizational
structure that contains elements of quality improvement, education, and research with the …

Stroke, thromboembolism, and bleeding are the most recognized complications associated
with pediatric ventricular assist devices (VADs) and the leading cause of death and disability …

Methods: A search of peer-reviewed scientific studies published in English from 1990− 2020
using the PubMed database with keywords including extracorporeal membrane oxygenation …